...
首页> 外文期刊>International Journal of Legal Medicine >Prevalence of adverse drug combinations in a large post-mortem toxicology database
【24h】

Prevalence of adverse drug combinations in a large post-mortem toxicology database

机译:大型验尸毒理学数据库中不良药物组合的患病率

获取原文
获取原文并翻译 | 示例
           

摘要

The prevalence of important adverse drug combinations was studied among the 37,367 cases included in the Finnish post-mortem toxicology database during 2000–2006. The new SFINX interaction database (Swedish, Finnish, INteraction X-referencing) was utilised to identify adverse drug combinations. Consequently, the 24 drugs chosen for the study generated 96 two-compound combinations possessing potentially severe interactions. The total number of hits for the combinations found in the post-mortem database was 267, which accounts for approximately 0.71% of all cases. The potential role of adverse drug interaction (ADI) in these cases was evaluated from the background information and death certificate. The possible ADI cases comprised 23% of all hits and 0.17% of all cases analysed. In cases with a pharmacodynamic mechanism, the most prominent combinations were medicines causing serotonin syndrome or a β1-blocker with verapamil or diltiazem. In cases with a pharmacokinetic mechanism, half of the cases involved digoxin in combination with verapamil. In one third of the possible ADI cases, a forensic pathologist had noted the studied compounds as an underlying or contributing cause of death, although the agents’ specific role in ADIs was rarely recognised.
机译:在2000-2006年间,芬兰死后毒理学数据库中包括的37,367例病例中,对重要不良药物组合的患病率进行了研究。新的SFINX交互作用数据库(瑞典语,芬兰语,INTELACTION X参考)用于识别不良药物组合。因此,为该研究选择的24种药物产生了96种具有潜在严重相互作用的二化合物组合。事后数据库中找到的组合的总点击数为267,约占所有案件的0.71%。从背景资料和死亡证明书中评估了这些案例中药物不良相互作用(ADI)的潜在作用。可能的ADI病例占所有命中病例的23%,占所有分析病例的0.17%。在具有药效学机制的病例中,最主要的组合是引起血清素综合征或β 1 阻滞剂与维拉帕米或地尔硫卓的药物。在具有药代动力学机制的病例中,一半病例涉及地高辛与维拉帕米联用。法医病理学家指出,在可能的ADI病例的三分之一中,虽然很少认识到这些药物在ADIs中的特殊作用,但它们是潜在的或造成死亡的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号